#FECMM
@efisg-escmid.bsky.social Chair 2024-26
YoungEHA Committee member 2025-
@fungiscope.bsky.social #VACCELERATE #EPICOVIDEHA
#hematology #mycoses #ViralRespiratoryInfections
Still looking for cases of viral respiratory infections 🦠 of any kind within #EPICOVIDEHA / #EPIRESEHA 🧬
Always a pleasure to exchange ideas with our Italian colleagues! 🇮🇹
Still looking for cases of viral respiratory infections 🦠 of any kind within #EPICOVIDEHA / #EPIRESEHA 🧬
Always a pleasure to exchange ideas with our Italian colleagues! 🇮🇹
Findings show critical inequities in access to mycology labs, antifungal drugs, and @who.int-recommended diagnostics.
Full study 👉 www.sciencedirect.com/science/arti...
Findings show critical inequities in access to mycology labs, antifungal drugs, and @who.int-recommended diagnostics.
Full study 👉 www.sciencedirect.com/science/arti...
Mon, Oct 27 (from 15:45, poster area)
🧬P1301 – Respiratory viruses in hem/onc
🦠P1303 – hMPV vs Influenza vs SARS-CoV-2
🧫P1304 – RSV vs Influenza vs SARS-CoV-2
🇵🇪P1305 – IFI dx and tx capacity - Peru
🇭🇳P1306– IFI dx and tx capacity - Honduras
Mon, Oct 27 (from 15:45, poster area)
🧬P1301 – Respiratory viruses in hem/onc
🦠P1303 – hMPV vs Influenza vs SARS-CoV-2
🧫P1304 – RSV vs Influenza vs SARS-CoV-2
🇵🇪P1305 – IFI dx and tx capacity - Peru
🇭🇳P1306– IFI dx and tx capacity - Honduras
🕚 11:00 (S/T rooms) – Ceftazidim-avibactam in action
🕕 18:55 (Poster area) – Antifungal stewardship spotlight
@dgho_ev
🕚 11:00 (S/T rooms) – Ceftazidim-avibactam in action
🕕 18:55 (Poster area) – Antifungal stewardship spotlight
@dgho_ev
🗓️ Sat, 25 Oct | 17:45 | Postehalle
🦟 P416 #Dengue in hem/onc
🍄 P417 #Mucorales experience
💊 P418 #ISAV introduction
🧫 P419 #Aspergillus experience
🗓️ Sat, 25 Oct | 17:45 | Postehalle
🦟 P416 #Dengue in hem/onc
🍄 P417 #Mucorales experience
💊 P418 #ISAV introduction
🧫 P419 #Aspergillus experience
In 258 patients from 18 countries, 20% had ≥5 days of (+) cultures → higher mortality (50% vs 32%).
Low EQUAL #Candida Scores predicted persistence
💡 Adherence saves lives
🔗 www.journalofinfection.com/article/S016...
In 258 patients from 18 countries, 20% had ≥5 days of (+) cultures → higher mortality (50% vs 32%).
Low EQUAL #Candida Scores predicted persistence
💡 Adherence saves lives
🔗 www.journalofinfection.com/article/S016...
#Fluco-R #Candida_parapsilosis is a growing threat in hospitals.
In a #multicenter matched cohort study, #echinocandins and #LAmB showed comparable outcomes for bloodstream infections
journals.asm.org/doi/epub/10....
@escmid.bsky.social @taescmid.bsky.social
#Fluco-R #Candida_parapsilosis is a growing threat in hospitals.
In a #multicenter matched cohort study, #echinocandins and #LAmB showed comparable outcomes for bloodstream infections
journals.asm.org/doi/epub/10....
@escmid.bsky.social @taescmid.bsky.social
🦠 Explore #RSV, #influenza, #hMPV and more in hematology with experts
@olivercornely.bsky.social @salmantongarcia.bsky.social
Register 👉 uni-koeln.zoom.us/meeting/regi...
🦠 Explore #RSV, #influenza, #hMPV and more in hematology with experts
@olivercornely.bsky.social @salmantongarcia.bsky.social
Register 👉 uni-koeln.zoom.us/meeting/regi...
🔬 @BioMedCentral #Immunology is inviting submissions for our Collection on #Fungal Infections!
📅 Deadline: 26 June 2026
🌍 Topics:
Fungal pathogenesis
Immune responses
Antifungals
Precision medicine
& more...
👉 Submit here: www.biomedcentral.com/collections/...
🔬 @BioMedCentral #Immunology is inviting submissions for our Collection on #Fungal Infections!
📅 Deadline: 26 June 2026
🌍 Topics:
Fungal pathogenesis
Immune responses
Antifungals
Precision medicine
& more...
👉 Submit here: www.biomedcentral.com/collections/...
💉 Weekly echinocandin in invasive candidiasis/candidemia
🏥 15 pts | 4 countries
✅ Feasible for outpatients
💪 Active vs resistant #Candida
🛑 Access + admin barriers
👉 Real-world insights!
onlinelibrary.wiley.com/doi/epdf/10....
💉 Weekly echinocandin in invasive candidiasis/candidemia
🏥 15 pts | 4 countries
✅ Feasible for outpatients
💪 Active vs resistant #Candida
🛑 Access + admin barriers
👉 Real-world insights!
onlinelibrary.wiley.com/doi/epdf/10....
▫️ 25% persisted despite therapy
▫️ Linked to C. parapsilosis & C. auris
▫️ Source control protective
▫️ Persistence ↑ 30d mortality
🔗 www.journalofinfection.com/article/S016...
▫️ 25% persisted despite therapy
▫️ Linked to C. parapsilosis & C. auris
▫️ Source control protective
▫️ Persistence ↑ 30d mortality
🔗 www.journalofinfection.com/article/S016...
📅Sáb 30 AGO 2025 | 8:00-14:00
📍Auditorio Megalabs, Caracas y💻Virtual
🎙Expertos de 🇻🇪🇨🇴🇧🇷🇵🇾🇲🇽
💲Prof. $20 | Est. $10 | Online $20
🔗Registro: forms.gle/xAUJcaWw72y4...
✉ MicologiaVenezuela.AVM@gmail.com | @avmycolve
📅Sáb 30 AGO 2025 | 8:00-14:00
📍Auditorio Megalabs, Caracas y💻Virtual
🎙Expertos de 🇻🇪🇨🇴🇧🇷🇵🇾🇲🇽
💲Prof. $20 | Est. $10 | Online $20
🔗Registro: forms.gle/xAUJcaWw72y4...
✉ MicologiaVenezuela.AVM@gmail.com | @avmycolve
Hotels within the transport area #1
Check flight companies flying to #Bilbao: en.wikipedia.org/wiki/Bilbao_...
Hotels within the transport area #1
Check flight companies flying to #Bilbao: en.wikipedia.org/wiki/Bilbao_...
🧪 Microscopy? Widespread.
💊 Antifungals? Some gaps.
🧬 Advanced tools? Still growing.
💡 A call for smarter investment in fungal care → journals.asm.org/doi/10.1128/...
@jmaquera2 @olivercornely.bsky.social
🧪 Microscopy? Widespread.
💊 Antifungals? Some gaps.
🧬 Advanced tools? Still growing.
💡 A call for smarter investment in fungal care → journals.asm.org/doi/10.1128/...
@jmaquera2 @olivercornely.bsky.social
Good job Lukas!
Good job Lukas!